科學家發現胰臟癌的新治療標靶
Scientists Discover New Treatment Target for Pancreatic Cancer
胰臟癌長期以來都是最難治療的疾病之一，主要是因為它往往在晚期才被發現，且被一層緻密、具抗藥性的環境所保護。
Pancreatic cancer has long been one of the most challenging diseases to treat, primarily because it is often discovered in late stages and protected by a dense, drug-resistant environment.
研究人員正利用人工智慧和基因組圖譜來識別那些曾被認為「無法投藥」的弱點，例如曾經難以捉摸的 KRAS 基因突變和 STAT3 蛋白質。
Researchers are now using AI and genomic mapping to identify "undruggable" vulnerabilities, such as the once-elusive KRAS mutation and the STAT3 protein.
一項開創性的發現涉及「隱蔽肽」(cryptic peptides)，這些肽僅出現在腫瘤細胞上，有潛力開發出能殺死癌細胞同時避開健康組織的療法。
One groundbreaking discovery involves "cryptic peptides," which appear exclusively on tumor cells, potentially allowing for treatments that kill cancer while sparing healthy tissue.
另一種有前景的方法則涉及 SPP1 蛋白質，當阻斷該蛋白質時，即可停止腫瘤擴散。
Another promising approach involves the protein SPP1, which, when blocked, can stop tumor spread.
此外，專家正透過聲學聚集療法 (Acoustic Cluster Therapy) 等創新輸送系統來克服腫瘤的保護屏障，該療法利用超音波將藥物直接釋放在病灶。
Furthermore, experts are overcoming the tumor’s protective barrier using innovative delivery systems like Acoustic Cluster Therapy, which uses ultrasound to release drugs directly at the site.
這些進展，加上即時適應性放療和早期生物標記物檢測，標誌著從廣譜化學治療向精準醫學的重大轉移。
These advancements, combined with real-time adaptive radiation and early biomarker detection, mark a major shift away from broad-spectrum chemotherapy toward precision medicine.
科學家對此持樂觀態度，相信這些標靶策略將把胰臟癌護理從一種治療選項有限的診斷結果，轉變為可控制的病況，並提供個人化且有效的解決方案。
Scientists remain optimistic that these targeted strategies will transform pancreatic cancer care from a diagnosis with limited options into a manageable condition with personalized, effective solutions.
